Chou Chia-Wei, Chen Ching-Chow
Department of Pharmacology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Road, 1st Section Taipei 10018, Taiwan.
FEBS Lett. 2008 Dec 10;582(29):4059-65. doi: 10.1016/j.febslet.2008.10.048. Epub 2008 Nov 11.
HDAC inhibitors are promising anticancer agents that induce cell cycle arrest and apoptosis. However, the role of HDACs in cancer progression, such as angiogenesis and metastasis, remains largely unexplored. Among various HDAC inhibitors, we demonstrate that TSA and SAHA upregulated the expression of angiostatic ADAMTS1 in A549 cells. HDAC6 inhibitor tubacin, and knockdown of HDAC6, also lead to ADAMTS1 upregulation. By reporter, DAPA, and ChIP assays, the proximal GC boxes were demonstrated to be essential for ADAMTS1 induction. Decreased binding of SP1 and HDAC6 to the ADAMTS1 promoter after TSA treatment was also seen. These data suggest the involvement of HDAC6 and SP1 in the HDACi-induced expression of angiostatic ADAMTS1.
组蛋白去乙酰化酶(HDAC)抑制剂是很有前景的抗癌药物,可诱导细胞周期停滞和凋亡。然而,HDAC在癌症进展(如血管生成和转移)中的作用在很大程度上仍未得到探索。在各种HDAC抑制剂中,我们证明曲古抑菌素A(TSA)和伏立诺他(SAHA)上调了A549细胞中血管抑制性含血小板反应蛋白基序的解聚蛋白样金属蛋白酶1(ADAMTS1)的表达。HDAC6抑制剂tubacin以及HDAC6的敲低也导致ADAMTS1上调。通过报告基因、DAPA和染色质免疫沉淀(ChIP)分析,近端GC盒被证明对ADAMTS1的诱导至关重要。TSA处理后,SP1和HDAC6与ADAMTS1启动子的结合减少也被观察到。这些数据表明HDAC6和SP1参与了HDAC抑制剂诱导的血管抑制性ADAMTS1的表达。